PubMed COVID-19 Clinical Care

CONCLUSION: The results demonstrated moderate knowledge about COVID-19 among study participants, with significant differences between the responses of males and females and among the urban and rural populations. Outcomes suggest the need for

Shufeng Jiedu Capsule (SFJDC), composed of eight herbs, is a big brand traditional Chinese medicine (TCM) for the treatment of different respiratory tract infectious diseases with good clinical efficacy and few side effects. It is clinically applied

CONCLUSIONS: Fewer patients were referred to specialised palliative care during the pandemic, and fewer were screened for palliative care needs. In future pandemics or similar scenarios, it is important to pay special attention to referral rates and

CONCLUSIONS: The ChAdOx1 nCov-19 vaccine is apparently safe and effective against SARS-CoV-2 virus infection. Prior COVID infection and younger age group achieve higher antibody titers, but no additional protection. Delaying the second dose up to at

Precisely detecting the ultra-low-level severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial. The detection mechanism must be sensitive, low-cost, portable, fast, and easy to operate to tackle coronavirus disease 19 (COVID-19)

CONCLUSION: This study adds to the growing literature on the association of the COVID-19 pandemic on ED trends and the need for future public health and service provision funding to be allocated for mental health services during periods of

No abstract

CONCLUSION: Compliance with legislation fuels the psychological need of protection in patients, which is a key determinant of motivation in the context of the pandemic. Considering patients' self-regulatory activities to assess motivational factors

Urban green space (UGS) provides multiple cultural ecosystem services (CES) and enhances people's physical and mental well-being. The importance of UGS was more critical during crisis periods such as the COVID-19 pandemic. Recently, UGS has been

Infection remains a significant contributor to morbidity and mortality in patients with myeloma. This guideline was developed by a multidisciplinary group of clinicians who specialise in the management of patients with myeloma and infection from the